The affirmation is a result of YVMH’s dominant market position. Moody’s also acknowledged the hospital’s unfavorable payer mix, modest liquidity position and unstable operating performance.
The outlook was revised to negative from stable, reflecting the hospital’s weaker operating performance through the third quarter of fiscal year 2017.
More articles on healthcare finance:
Why Harvard’s $37B endowment is at risk of mediocrity
12 hospitals seeking RCM talent
Irving family presents record $700M bequest to NewYork-Presbyterian, Columbia University
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
